PP82
Layer-by-layer functionalisation of polymeric
blends to favor stent endothelialisation
I Carmagnola
1, V Chiono
1, S Cabodi
2, F Logrand
2and G Ciardelli
11
Department of Mechanical and Aerospace Engineering,
Politecnico di Torino, Torino, Italy;
2Department of Molecular
Biotechnology and Health Science, Molecular Biotechnology
Center, University of Turin, Torino, Italy
Introduction: Specific ligand immobilisation can enhance endothelial cells (ECs) adhesion on stent surface, avoiding migration of smooth muscle cells (SMCs) [1]. Wei et al. [2] demonstrated that the REDV peptide promote the EC growth respect to SMCs. In this work, poly-meric substrates were coated through layer-by-layer technique to func-tionalize thefinal layer with the CRETTAWAC sequence able to favor ECs and inhibit platelet attachment [3].
Materials and methods: Aminolysed poly(L-lactide)/poly(DL-lac-tide-co-glycolide) (PLLA/PLGA)films were dipped into alternate aque-ous solutions (0.5% w/v, pH: 4.5) of poly(sodium 4-styrene sulfonate) (PSS) and poly(diallyldimethylammonium chloride) (PDDA) for 15 minutes each, with intermediate washing steps in bidistilled water (pH: 4.5) for 5 minutes. Heparin (HE) was deposited as the last layer of the coating. Surface composition was evaluated through XPS analysis and via colorimetric method. The CRETTAWAC effect on re-endothelial-ization was evaluated using human umbilical vein endothelial cells (HUVECs). Cells were seeded onto three different surface: CRETTA-WAC, bovine serum albumin (BSA) andfibronectin (FN).
Results: The deposition of multilayer coating was confirmed by XPS analysis.
Table 1. Atomic percentage of chemical elements of functionalised sam-ples.
C1s O1s N1s S2p
Aminolyzed PLLA/PLGA 64.0 35.3 0.7 –
PLLA/PLGA+ 14L 71.2 26.0 1.3 1.5
PLLA/PLGA+ 15L 70.2 25.8 2.2 1.8
After the deposition of 14 and 15 polyelectrolyte layers the percent-age of N and S was higher respect to aminolysed PLLA/PLGA due to the deposition of PDDA, PSS and HE (Table 1). In vitro tests show that after 2 hours the number of adhered cells on CRETTAWAC functiona-lised substrate were less respect to FN. After 4 hours HUVECs seeded on CRETTAWAC showed a spread shape.
Discussion and conclusions: Through the LbL technique allows to obtain functional coatings without changing the bulk properties. CRETTAWAC sequence was shown to bind the a5b1 integrin that is present on the surface of ECs but lacking on platelets. LBL could be exploited for sur-face functionalisation with KKKKKKSGSSGKCRRETAWAC, able to elec-trostatically interact with HE.
Acknowledgments: NANOSTENT (Regional Project, Regione Pie-monte).
References
1. Smith E.J., Rothman M.T., J. Interv. Cardiol. 16, 475, 2003. 2.Wei Y., Ji L-L., Xiao Q-k., Lin J-p., Xu K-f., Ren J. Ji, Biomaterials 34, 2588, 2013.
3. Meyers S.R., Kenan D.J., Khoo X., Grinstaff M.W., Biomacomolecules 12, 533, 2011.
PP83
Realization of a soft-MI electrospun scaffold for
tissue engineering applications
G Criscenti
1, G Cerulli
2, D Saris
1, C Van Blitterswijk
1, G Vozzi
3,
H Fernandes
1and L Moroni
11
Department of Tissue Regeneration, MIRA Institute for
Biomedical Technology and Technical Medicine, Faculty of Science
and Technology, University of Twente, Enschede, The Netherlands;
2
Istituto di Ricerca Traslazionale per l’Apparato Locomotore –
Nicola Cerulli
– LPMRI, University of Perugia, Arezzo, Italy;
3
Research center
“E. Piaggio”, Faculty of Engineering, University
of Pisa, Pisa, Italy
Introduction: The fabrication of bioactive scaffolds able to mimic the in vivo cellular microenvironment represents a challenge for tissue engineering (TE). In the present work, we propose the combination of electrospinning (ESP) and soft-molecular imprinting (soft-MI) [1] to create a soft-molecular imprintedfibrous scaffold for TE applica-tions. By combining these techniques, we fabricated poly-L-lactide acid (PLLA), PolyActive (PA) and poly lactic-co-glycolic acid (PLGA) based scaffolds functionalized using different protein arranged onto the surface.
Materials and methods: A functionalized PDMS mold was used as a tar-get for the ESP jet. The PDMS mold was prepared using a commercial product (Sylgard 184 kit, Dow Corning, MI) with a 10:1 (w/w) ratio. The mixture was casted onto a silica wafer comprising different cus-tom-made geometries, degassed, and finally cured in an oven for 4 hours at 70°C. To reduce the hydrophobicity of its surface, the PDMS mold was treated with Piranha Solution (3:1). After the derivatization of its surface with a 1% solution of (3-Aminopropyl)-trimethoxysilane in Toluene, the PDMS mold was activated with an EDC-NHS solution. Finally, the mold was immersed in a protein solution for 24 hours. The proteins used as templates were FITC-albumin and TRITC-lectin. Three different polymer solutions were prepared: PLGA 4% (w/v) in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), PLDLA 5% (w/v) in HFIP and PA300 20% (w/v) in CHCl3/HFIP 70:30 (v/v). The functionalized
PDMS mold was positioned under the ESP jet and the ESPfibers fabri-cated at aflow rate of 1 mL/h and a voltage of 20 kV. The imprinted scaffolds were tested for their ability to rebind the template protein and observed with afluorescence microscope. To evaluate the selectivity for a particular template molecule, the imprinted scaffolds were immersed in a solution of both FITC-albumin and TRITC-lectin. The obtained scaffolds were analyzed byfluorescence microscopy to ensure that no weakly bound protein on the PDMS was transferred to them.
Figure 1. Microscopy images of adhered HUVECs on different func-tionalised surface after 4 hours.
© 2014 The Authors. J Tissue Eng Regen Med 2014;8 (Suppl. 1): 207–518.
Journal of Tissue Engineering and Regenerative Medicine© 2014 John Wiley & Sons, Ltd. DOI: 10.1002/term.1932
Results: The imprinted scaffolds demonstrated affinity and selectivity for their template molecule over the otherfluorescent protein competi-tor. Specifically, the FITC-albumin imprinted scaffolds showed protein absorption in a solution of FITC-albumin (Fig. 1a) while no protein adsorption was seen in a solution of TRITC-lectin. Similar results were obtained with the TRITC-lectin imprinted scaffolds (Fig. 1b).
Figure 1. (a) FITC-albumin imprinted PLGA scaffold; (b) TRITC-lectin imprinted PLGA scaffold.
Discussion and conclusions: The integration of ESP and soft-MI repre-sents a promising technique for the realization of scaffolds for TE appli-cations, because it allow us to mimic the biological environments through the selective bindings of specific endogenous proteins. Reference
1. Vozzi G. et al., Biotechnology and bioengineering, 2010. 106(5), 804–17.
PP84
Electrospun microyarns for vascularization
in tissue engineering
K Rietzler
1, K Feher
1, S Weinandy
2, M Kruse
1, P Schneider
3,
T Gries
1and S Jockenhoevel
21
Institut fuer Textiltechnik an der RWTH Aachen University,
RWTH Aachen University, Aachen, Germany;
2AME-Helmholtz
Institute for Biomedical Engineering, RWTH Aachen University,
Aachen, Germany;
3Department for Textile Technology- Technical
Textiles, HS Albstadt- Sigmaringen, Albstadt, Germany
Introduction: As an interdisciplinaryfield Tissue Engineering is aiming at the reproducibility of damaged tissue or organs. Although there are constantly achieved successes in the design of tissue engineered con-structions, there is still the difficulty to provide those with a sufficient vascularization. Successful applications in Tissue Engineering involve thin avascular tissue like cartilage and skin without a vasculature.
Aim of the present research work is the production of electrospun mi-croyarns to support angiogenesis infibrin gel scaffolds.
Materials and methods: Microyarns with different morphological prop-erties (polymer concentration, polymer blend, diameter, torsion angle) were produced by electrospinning[1]. Polylactide (PLA) and
polyethyl-ene glycol (PEG) were used as polymers. The electrospun microyarns were UV- sterilized for 30 minutes under the laminarflow hood. After sterilization the microyarns were seeded with 1.49 106human umbili-cal vein endothelial cells (HUVECs) and incubated (37°C, 5%CO2) in
24-well plates for 24 hours. Subsequently the microyarns were stained with 40,6-Diamidin-2-phenylindol (DAPI) and analyzed under the fluo-rescence microsope[2]. Those of the microyarns that showed the best
proliferations were used for further experiments. To proof their capabil-ity of developing capillary-like structures, the microyarns were culti-vated in 3D. The micoyarns werefirst seeded in 24 well plates with HUVECs; then embedded infibrin gel containing both HUVECs and human dermal foreskinfibroblasts (HDFFs). After 14 days of co-culti-vation thefibrin gels were fixed and immunostained (CD31). Verifica-tion and quantification of the capillary-like structures were implemented by two-photon laser scanning microscopy (TPLSM) and ImagePro Analyzer software. All experiments were replicated three times with different donors.
Results: After 14 days of co-cultivation, it could be observed that there is formation of capillary-like structures within the HUVEC/HDFF co-cul-ture system. There were also significant distinctions in formation between the different morphological properties of the microyarns.
Figure 1. Cell adhesion on PLA/PEG microyarn (l), SEM image of PLA/ PEG microyarn (r).
Discussion and conclusions: The present work shows, that microyarns can be applied as textile scaffolds for vascularization. Depending on their morphological property, they are also capable to influence the ori-entation of cell adhesion.
References
1. Dalton P., Klee, D. et al., Polymer 46:3, 611-614. 2005.
2. Sorrell J, Baber M, et al., Cells Tissues Organs.186:157-68. 2007.
PP85
Fabrication of a functionally layered membrane
designed for periodontal tissue regeneration
P Gentile, JK Atkinson, CA Miller and PV Hatton
School of Clinical Dentistry, University of Sheffield, Sheffield, UK
Introduction: Guided bone regeneration (GBR) is employed in dental implantology and the treatment of periodontal bone loss. It is based on the surgical placement of a barrier membrane that excludes soft tissue growth that would otherwise prevent bone healing [1-2].Unfortunately, non-resorbable membranes require a second operation for their removal while resorbable collagen membranes have an associated risk of disease transmission, and also existing commercial systems do not promote tissue regeneration beyond their barrier function. The aim was therefore to develop a functionalised, bilayered resorbable membrane with a dense layer to contact soft tissues, and a porous layer to promote bone healing.Materials and methods: Compact films of poly(D,L-lactide-co-glyco-lide) (PLGA, 75:25) were prepared by solvent casting from acetone. Porous membranes were prepared by dissolving PLGA (22% w/v) and nano-hydroxyapatite powder (20% w/w) [3] in acetone prior to electrospinning. Both layers were subjected to plasma polymerisation for acrylic acid grafting, and were modified by layer-by-layer (LbL) technique to generate functional polyelectrolyte (poly (styrene sulfo-nate) /poly(allyl amine) (PSS/ PAH); Sigma) to obtain 20 nanolayers to incorporate (1) an antibiotic drug (Metronidazole; Sigma) to pro-vide antibacterial activity for the compact layer, and (2) specific bone matrix peptides (KRSR and FHRRIKA; GenScript) to promote bone healing at the porous surface. The layers were assembled usingfibrin glue. Drug release from the compact layer was evaluated by UV-Vis, while in vitro biocompatibility was investigated using L292 mouse fi-broblasts (compact layer) and rat mesenchymal stromal cells (porous layer).
Results and discussion: FTIR-ATR showed that the typical absorption bands of PAH and PSS increased with layer number (i.e. SO3 stretching vibrations at 1130/cm for PSS, and NH scissoring vibra-tions at 1580/cm for PAH). The contact angle values had an alter-nate behaviour from the 9th and from 11th nanolayer for the compact and porous layer respectively. XPS spectra showed a N1s
peak at 399.5 eV and S2ppeak at 168 eV, indicating PAH and PSS
had been introduced (Fig. 1).
© 2014 The Authors. J Tissue Eng Regen Med 2014;8 (Suppl. 1): 207–518.
Journal of Tissue Engineering and Regenerative Medicine© 2014 John Wiley & Sons, Ltd. DOI: 10.1002/term.1932